Equativ and Sharethrough Will Now Operate Under Equativ Brand, Solidifying Global Position as Leading End-to-End Media Platform

Following its merger with Sharethrough, Equativ has tripled in size over three years, expanding global reach and accelerating growth in North America

NEW YORK, June 09, 2025 (GLOBE NEWSWIRE) — Equativ today announces the full unification of Sharethrough into its global brand and operations, forming one of the largest global independent media platforms and marketplaces, strengthening its ability to serve global advertisers and publishers with transparency, innovation, and user-first technology. Additionally, Equativ benefits from a complete rebrand of its visual identity and website.

This milestone celebrates the unification of both companies under one roof, and marks the final step in a year-long integration process following Equativ’s acquisition of Sharethrough in June 2024.

Equativ Unveils its New Brand Identity: Equativ new brand identity

A Media Snippet accompanying this announcement is available in this link

Over the past year, the combined power of Equativ and Sharethrough has significantly accelerated its growth, firmly establishing Equativ as a leading independent platform trusted by thousands of global brands and all of the Big Six agencies. Strategic partnerships with major players like Deutsche Telekom and Titan OS, and the acquisition of Kamino Retail further demonstrate Equativ’s commitment to innovation and global reach and role as a preferred partner for results-driven marketers.

“This is more than a rebrand—it’s the culmination of a common vision to build a more dynamic, innovative, and more outcomes-driven alternative to today’s fragmented ad tech landscape,” said Ben Skinazi, Chief Marketing Officer, Equativ. “Together, we’ve built a global platform that’s designed for interoperability, intelligence, and results across the entire media journey.”

The new Equativ brings together planning, curation, activation, ad enhancement and optimization within one media platform: Maestro by Equativ, offering brands and agencies one entry for multiple solutions for driving outcomes in today’s attention economy. With omnichannel capabilities across CTV, video, native, display, and retail media, Equativ simplifies the ad tech stack and delivers performance while providing quality media, meeting the demands of a fast-changing media landscape.

In a moment where innovation and performance are paramount, the unification of Sharethrough and Equativ represents a powerful leap forward. By combining their complementary strengths, we’re advancing sustainability, transparency, and creativity—enabling Horizon to deliver bold, breakthrough results for our most ambitious, performance-driven clients,” expressed Alex Stone, SVP, Agency Partnerships & Advanced Video, Horizon Media.

Co-Founder and CEO at Scope3, Brian O’Kelley declared: “I’m truly excited about what the future holds for Equativ, as Sharethrough and Equativ come together under one name. From pioneering green media products to being early adopters of Scope3’s agentic technology, both companies have consistently pushed the industry forward. With the strength of their combined teams and platforms, I believe this unified company will have an even greater impact on the future of programmatic media.”

Being Equativ’s Strategic Advisor for the past two years, Mykim Chikli, former CEO of Publicis Group in EMEA and Asia and CEO of Weborama in France, testified, “As someone who has spent decades on the agency side working with global brands, I’ve seen firsthand how the industry has evolved—and how fragmented and complex it has become. What Equativ has achieved through this unification is not just scale but clarity: a platform that simplifies execution, respects the user experience, and delivers real and sustainable outcomes. It’s exactly the kind of partner agencies and advertisers need in today’s market.”

“The Equativ platform is robust, flexible, and well-suited to our application environment. Equativ’s teams are responsive, attentive, and always ready to optimize the setup. It’s a truly trusted partnership that allows us to combine advertising performance and technological expertise,” stated Vincent Salini, Digital Sales Director at France TV Advertising.

About Equativ

Equativ is a global, end-to-end media platform empowering advertisers and publishers to achieve real outcomes by uniting premium inventory and audiences with advanced curation and cutting-edge ad tech across all channels. Purpose-built for the attention economy, Equativ delivers quality, engagement, and performance while prioritizing respectful, user-centric ad experiences. With a team of over 750 professionals across 20 countries, Equativ combines global scale with deep local expertise. Learn more at Equativ.com.

For Media Inquiries: Please contact: Caroline Millié Figueiredo [email protected]

GlobeNewswire Distribution ID 9464581

Unity Group Unveils World’s First ESG Light Certified for Carbon Credits, Delivering Nearly 90% Energy Savings

HONG KONG SAR – EQS Newswire – 9 June 2025 – As sustainable development continues to gain momentum worldwide, the carbon emissions market presents immense growth potential. Hong Kong-listed Unity Group Holdings International Ltd (Unity) (1539.HK) recently unveiled the world’s first ESG Light certified for carbon credits. Its continued promotion will support global sustainability efforts while unlocking substantial growth opportunities for the company.

2025 Carbon Credit and ESG Ecosystem Conference

Unveiling World’s First ESG Carbon-Credit Light

At the Carbon Credit and ESG Ecosystem 2025 Conference held at Universiti Putra Malaysia, Synergy ESCO, the Malaysian subsidiary of Unity Group, unveiled the world’s first ESG Light certified for carbon credit eligibility.

Appearing like a conventional lighting fixture, the ESG Light integrates advanced energy-saving technologies, offering ultra-high energy efficiency and an exceptionally long lifespan. Operating at 4.5 watts, it delivers an estimated 89% energy savings compared to traditional lighting. Its projected lifespan is 180,000 hours. It could function for approximately 40 years based on 12 hours of daily use.

Its greatest advantage is to generate carbon credits. Synergy can claim corresponding carbon emission rights and trade them in the carbon market, making such product a valuable financial asset.

Unity Group plans to partner with the Selangor State Government in Malaysia on the Green One Day community programme, retrofitting 6,000 apartment units with its ESG Lights. It is expected to reduce carbon emissions by approximately 25 million tons of CO₂, equivalent to the carbon absorption capacity of 630 million trees.​​ Over the next decade, Unity Group stands to benefit from the ongoing generation of carbon credits under this project.

Unity Group operates across a range of sectors, including independent energy-saving solutions, renewable energy, and ESG-driven digital vertical indoor farming.

It is also the first company to implement carbon credit management. Through the promotion of such product, it is driving large-scale energy savings and emissions reductions, while generating revenue through carbon trading. The launch of this light marks an important milestone for Unity Group.

Expanding Multi-Sector Adoption to Advance Sustainable Development

The concept of sustainable development is gaining widespread momentum. To meet their sustainability goals, countries are ramping up efforts to promote and adopt a variety of energy-saving and emission-reduction technologies and products. Take China for example,clean energy sources like wind and solar power are experiencing rapid growth. In the first quarter of this year, the installed capacity of wind and solar energy surpassed that of coal-fired power for the first time.

Malaysia has also set a net-zero emission target, committing to achieving carbon neutrality by 2050. It is working to significantly increase its share of renewable energy consumption to meet this goal.

In February 2022, Unity Group undertook a large-scale energy-saving project in Selangor, Malaysia. It aimed to improve lighting efficiency in residential buildings by installing ultra-high-efficiency lighting systems. The total energy savings generated during the contract term will be converted into revenue.

Besides, Unity Group plans to integrate its ESG Lights into digital ESG agriculture. This project is expected to cut energy consumption by 70% while increasing crop yields tenfold. Once this model is implemented, it will unlock significant growth potential for Unity Group. Adoption of related products across various sectors will also contribute to global sustainable development.

Today, Unity Group’s operations span Malaysia, Chinese Mainland, Hong Kong, Japan, Indonesia, the Middle East, South Africa, and other regions. Unity Group is also actively pursuing a listing in Malaysia, which could make it the first Hong Kong-listed firm to achieve such a dual listing in Malaysia.

 

IBTA IMPORTANT DEADLINE: ROSEN, TRUSTED INVESTOR COUNSEL, Encourages Ibotta, Inc. Investors with Losses in Excess of $100K to Secure Counsel Before Important June 16 Deadline in Securities Class Action First Filed by the Firm – IBTA

NEW YORK, June 08, 2025 (GLOBE NEWSWIRE) —

WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of securities of Ibotta, Inc. (NYSE: IBTA): (1) pursuant and/or traceable to the registration statement and related prospectus (collectively, the “Registration Statement”) issued in connection with Ibotta’s April 18, 2024 initial public offering (the “IPO”); or (2) between April 18, 2024 and February 26, 2025, inclusive (the “Class Period”), of the important June 16, 2025 lead plaintiff deadline in the securities class action first filed by the Firm.

SO WHAT: If you purchased Ibotta securities you may be entitled to compensation without payment of any out of pocket fees or costs through a contingency fee arrangement.

WHAT TO DO NEXT: To join the Ibotta class action, go to https://rosenlegal.com/submit-form/?case_id=36526 or call Phillip Kim, Esq. toll-free at 866-767-3653 or email [email protected] for information on the class action. A class action lawsuit has already been filed. If you wish to serve as lead plaintiff, you must move the Court no later than June 16, 2025. A lead plaintiff is a representative party acting on behalf of other class members in directing the litigation.

WHY ROSEN LAW: We encourage investors to select qualified counsel with a track record of success in leadership roles. Often, firms issuing notices do not have comparable experience, resources or any meaningful peer recognition. Many of these firms do not actually litigate securities class actions, but are merely middlemen that refer clients or partner with law firms that actually litigate the cases. Be wise in selecting counsel. The Rosen Law Firm represents investors throughout the globe, concentrating its practice in securities class actions and shareholder derivative litigation. Rosen Law Firm achieved the largest ever securities class action settlement against a Chinese Company at the time. Rosen Law Firm was Ranked No. 1 by ISS Securities Class Action Services for number of securities class action settlements in 2017. The firm has been ranked in the top 4 each year since 2013 and has recovered hundreds of millions of dollars for investors. In 2019 alone the firm secured over $438 million for investors. In 2020, founding partner Laurence Rosen was named by law360 as a Titan of Plaintiffs’ Bar. Many of the firm’s attorneys have been recognized by Lawdragon and Super Lawyers.

DETAILS OF THE CASE: According to the lawsuit, in the Registration Statement and/or throughout the Class Period, defendants made false and/or misleading statements and/or failed to disclose that: (1) Ibotta did not properly warn investors of the risk concerning Ibotta’s contract with Kroger; (2) Ibotta’s data measurement system did not provide accurate, precise, and real time client campaign and consumer data measurement; (3) Ibotta’s business mix had shifted and was generating less revenue; and (4) Ibotta had “exhausted” its clients’ budgets, negatively impacting fourth quarter 2024 revenue and expected first quarter 2025 revenue. When the true details entered the market, the lawsuit claims that investors suffered damages.

To join the Ibotta action, go to https://rosenlegal.com/submit-form/?case_id=36526 or call Phillip Kim, Esq. toll-free at 866-767-3653 or email [email protected] for information on the class action.

No Class Has Been Certified. Until a class is certified, you are not represented by counsel unless you retain one. You may select counsel of your choice. You may also remain an absent class member and do nothing at this point. An investor’s ability to share in any potential future recovery is not dependent upon serving as lead plaintiff.

Follow us for updates on LinkedIn: https://www.linkedin.com/company/the-rosen-law-firm, on Twitter: https://twitter.com/rosen_firm or on Facebook: https://www.facebook.com/rosenlawfirm/.

Attorney Advertising. Prior results do not guarantee a similar outcome.

Contact Information:

Laurence Rosen, Esq.
Phillip Kim, Esq.
The Rosen Law Firm, P.A.
275 Madison Avenue, 40th Floor
New York, NY 10016
Tel: (212) 686-1060
Toll Free: (866) 767-3653
Fax: (212) 202-3827
[email protected]
www.rosenlegal.com

GlobeNewswire Distribution ID 9465121

ZBIO FINAL DEADLINE: ROSEN, A GLOBAL AND LEADING LAW FIRM, Encourages Zenas BioPharma, Inc. Investors with Losses in Excess of $100K to Secure Counsel Before Important June 16 Deadline in Securities Class Action First Filed by the Firm – ZBIO

NEW YORK, June 08, 2025 (GLOBE NEWSWIRE) —

WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of the securities of Zenas BioPharma, Inc. (NASDAQ: ZBIO) pursuant and/or traceable to the registration statement and prospectus (collectively, the “Registration Statement”) issued in connection with Zenas BioPharma’s September 2024 initial public offering (“IPO” or the “Offering”), of the important June 16, 2025 lead plaintiff deadline in the securities class action first filed by the firm.

SO WHAT: If you purchased Zenas BioPharma securities you may be entitled to compensation without payment of any out of pocket fees or costs through a contingency fee arrangement.

WHAT TO DO NEXT: To join the Zenas BioPharma class action, go to https://rosenlegal.com/submit-form/?case_id=37109 or call Phillip Kim, Esq. toll-free at 866-767-3653 or email [email protected] for information on the class action. A class action lawsuit has already been filed. If you wish to serve as lead plaintiff, you must move the Court no later than June 16, 2025. A lead plaintiff is a representative party acting on behalf of other class members in directing the litigation.

WHY ROSEN LAW: We encourage investors to select qualified counsel with a track record of success in leadership roles. Often, firms issuing notices do not have comparable experience, resources or any meaningful peer recognition. Many of these firms do not actually litigate securities class actions, but are merely middlemen that refer clients or partner with law firms that actually litigate the cases. Be wise in selecting counsel. The Rosen Law Firm represents investors throughout the globe, concentrating its practice in securities class actions and shareholder derivative litigation. Rosen Law Firm achieved the largest ever securities class action settlement against a Chinese Company at the time. Rosen Law Firm was Ranked No. 1 by ISS Securities Class Action Services for number of securities class action settlements in 2017. The firm has been ranked in the top 4 each year since 2013 and has recovered hundreds of millions of dollars for investors. In 2019 alone the firm secured over $438 million for investors. In 2020, founding partner Laurence Rosen was named by law360 as a Titan of Plaintiffs’ Bar. Many of the firm’s attorneys have been recognized by Lawdragon and Super Lawyers.

DETAILS OF THE CASE: According to the lawsuit, the Registration Statement contained false and/or misleading statements and/or failed to disclose that: (1) Zenas BioPharma materially overstated the amount of time it would be able to fund its operations using existing cash and expected net proceeds from the IPO; and (2) as a result, defendants’ public statements were materially false and misleading at all relevant times and negligently prepared. When the true details entered the market, the lawsuit claims that investors suffered damages.

To join the Zenas BioPharma action, go to https://rosenlegal.com/submit-form/?case_id=37109 or call Phillip Kim, Esq. toll-free at 866-767-3653 or email [email protected] for information on the class action.

No Class Has Been Certified. Until a class is certified, you are not represented by counsel unless you retain one. You may select counsel of your choice. You may also remain an absent class member and do nothing at this point. An investor’s ability to share in any potential future recovery is not dependent upon serving as lead plaintiff.

Follow us for updates on LinkedIn: https://www.linkedin.com/company/the-rosen-law-firm, on Twitter: https://twitter.com/rosen_firm or on Facebook: https://www.facebook.com/rosenlawfirm/.

Attorney Advertising. Prior results do not guarantee a similar outcome.

——————————-

Contact Information:

        Laurence Rosen, Esq.
Phillip Kim, Esq.
The Rosen Law Firm, P.A.
275 Madison Avenue, 40th Floor
New York, NY 10016
Tel: (212) 686-1060
Toll Free: (866) 767-3653
Fax: (212) 202-3827
[email protected]
www.rosenlegal.com

GlobeNewswire Distribution ID 9464736

TMCI FINAL DEADLINE: ROSEN, NATIONAL TRIAL COUNSEL, Encourages Treace Medical Concepts, Inc. Investors with Losses in Excess of $100K to Secure Counsel Before Important June 10 Deadline in Securities Class Action – TMCI

NEW YORK, June 08, 2025 (GLOBE NEWSWIRE) —

WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of securities of Treace Medical Concepts, Inc. (NASDAQ: TMCI) between May 8, 2023 and May 7, 2024, both dates inclusive (the “Class Period”), of the important June 10, 2025 lead plaintiff deadline.

SO WHAT: If you purchased Treace Medical securities during the Class Period you may be entitled to compensation without payment of any out of pocket fees or costs through a contingency fee arrangement.

WHAT TO DO NEXT: To join the Treace Medical class action, go to https://rosenlegal.com/submit-form/?case_id=38284 or call Phillip Kim, Esq. toll-free at 866-767-3653 or email [email protected] for information on the class action. A class action lawsuit has already been filed. If you wish to serve as lead plaintiff, you must move the Court no later than June 10, 2025. A lead plaintiff is a representative party acting on behalf of other class members in directing the litigation.

WHY ROSEN LAW: We encourage investors to select qualified counsel with a track record of success in leadership roles. Often, firms issuing notices do not have comparable experience, resources, or any meaningful peer recognition. Many of these firms do not actually litigate securities class actions, but are merely middlemen that refer clients or partner with law firms that actually litigate the cases. Be wise in selecting counsel. The Rosen Law Firm represents investors throughout the globe, concentrating its practice in securities class actions and shareholder derivative litigation. Rosen Law Firm achieved the largest ever securities class action settlement against a Chinese Company at the time. Rosen Law Firm was Ranked No. 1 by ISS Securities Class Action Services for number of securities class action settlements in 2017. The firm has been ranked in the top 4 each year since 2013 and has recovered hundreds of millions of dollars for investors. In 2019 alone the firm secured over $438 million for investors. In 2020, founding partner Laurence Rosen was named by law360 as a Titan of Plaintiffs’ Bar. Many of the firm’s attorneys have been recognized by Lawdragon and Super Lawyers.

DETAILS OF THE CASE: According to the lawsuit, during the Class Period, defendants made false and/or misleading statements and/or failed to disclose that: (1) competition impacted the demand for and utilization of its primary product, the Lapiplasty 3D Bunion Correction System (the “Lapiplasty”); (2) as a result, Treace Medical’s revenue declined and Treace Medical needed to accelerate its plans to offer a product that was an alternative to osteotomy (a surgical procedure that involves cutting and realigning a bone to improve its position or function); and (3) defendants’ positive statements about Treace Medical’s business, operations, and prospects were materially misleading and/or lacked a reasonable basis. When the true details entered the market, the lawsuit claims that investors suffered damages.

To join the Treace Medical class action, go to https://rosenlegal.com/submit-form/?case_id=38284 call Phillip Kim, Esq. toll-free at 866-767-3653 or email [email protected] for information on the class action.

No Class Has Been Certified. Until a class is certified, you are not represented by counsel unless you retain one. You may select counsel of your choice. You may also remain an absent class member and do nothing at this point. An investor’s ability to share in any potential future recovery is not dependent upon serving as lead plaintiff.

Follow us for updates on LinkedIn: https://www.linkedin.com/company/the-rosen-law-firm or on Twitter: https://twitter.com/rosen_firm or on Facebook: https://www.facebook.com/rosenlawfirm.

Attorney Advertising. Prior results do not guarantee a similar outcome.

——————————-

Contact Information:

        Laurence Rosen, Esq.
Phillip Kim, Esq.
The Rosen Law Firm, P.A.
275 Madison Avenue, 40th Floor
New York, NY 10016
Tel: (212) 686-1060
Toll Free: (866) 767-3653
Fax: (212) 202-3827
[email protected]
www.rosenlegal.com

GlobeNewswire Distribution ID 9464727

King Abdullah II Discusses Middle East Stability with President Macron in Nice

Nice: His Majesty King Abdullah II, during a meeting with France President Emmanuel Macron on Monday, emphasized Jordan’s readiness to enhance ties with France across multiple sectors, contributing to stability in the Middle East.

According to Jordan News Agency, the two leaders underscored the significance of maintaining coordination on regional issues, increasing international efforts to achieve comprehensive calm in the region, reinstating the ceasefire in Gaza, and resuming humanitarian aid access.

His Majesty cautioned about the serious implications of ongoing escalations in the West Bank and Jerusalem, emphasizing that granting Palestinians their legitimate rights is essential for regional stabilization.

The King acknowledged France’s crucial role in supporting peace efforts in the Middle East based on the two-state solution, particularly through its organization of an international conference set to occur in New York from June 17-20, in partnership with Saudi Arabia.

The meeting, held on the sideli
nes of the third United Nations Ocean Conference, was attended by Deputy Prime Minister and Foreign Minister Ayman Safadi, Director of the Office of His Majesty Alaa Batayneh, and Jordan’s Ambassador to France Lina Al Hadid.